Logo image of SPNT

SIRIUSPOINT LTD (SPNT) Stock Fundamental Analysis

USA - NYSE:SPNT - BMG8192H1060 - Common Stock

17.99 USD
+0.23 (+1.3%)
Last: 10/21/2025, 8:04:01 PM
17.99 USD
0 (0%)
After Hours: 10/21/2025, 8:04:01 PM
Fundamental Rating

3

Overall SPNT gets a fundamental rating of 3 out of 10. We evaluated SPNT against 147 industry peers in the Insurance industry. SPNT has a bad profitability rating. Also its financial health evaluation is rather negative. SPNT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SPNT had positive earnings in the past year.
SPNT had a positive operating cash flow in the past year.
Of the past 5 years SPNT 4 years were profitable.
In the past 5 years SPNT always reported a positive cash flow from operatings.
SPNT Yearly Net Income VS EBIT VS OCF VS FCFSPNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

SPNT has a worse Return On Assets (0.84%) than 63.27% of its industry peers.
SPNT has a worse Return On Equity (4.90%) than 74.15% of its industry peers.
With a Return On Invested Capital value of 2.77%, SPNT perfoms like the industry average, outperforming 56.46% of the companies in the same industry.
Industry RankSector Rank
ROA 0.84%
ROE 4.9%
ROIC 2.77%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
SPNT Yearly ROA, ROE, ROICSPNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Profit Margin of SPNT (3.71%) is worse than 68.03% of its industry peers.
In the last couple of years the Profit Margin of SPNT has declined.
SPNT has a better Operating Margin (14.14%) than 65.99% of its industry peers.
SPNT's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.14%
PM (TTM) 3.71%
GM N/A
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
SPNT Yearly Profit, Operating, Gross MarginsSPNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SPNT is destroying value.
Compared to 1 year ago, SPNT has less shares outstanding
The number of shares outstanding for SPNT has been increased compared to 5 years ago.
SPNT has a better debt/assets ratio than last year.
SPNT Yearly Shares OutstandingSPNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SPNT Yearly Total Debt VS Total AssetsSPNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

The Debt to FCF ratio of SPNT is 4.88, which is a neutral value as it means it would take SPNT, 4.88 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.88, SPNT is in line with its industry, outperforming 42.18% of the companies in the same industry.
SPNT has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
SPNT has a Debt to Equity ratio of 0.32. This is comparable to the rest of the industry: SPNT outperforms 47.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.88
Altman-Z N/A
ROIC/WACC0.33
WACC8.5%
SPNT Yearly LT Debt VS Equity VS FCFSPNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SPNT Yearly Current Assets VS Current LiabilitesSPNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for SPNT have decreased strongly by -52.66% in the last year.
The earnings per share for SPNT have been decreasing by -14.97% on average. This is quite bad
SPNT shows a decrease in Revenue. In the last year, the revenue decreased by -1.01%.
SPNT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.87% yearly.
EPS 1Y (TTM)-52.66%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%-12.28%
Revenue 1Y (TTM)-1.01%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%-12.28%

3.2 Future

Based on estimates for the next years, SPNT will show a very strong growth in Earnings Per Share. The EPS will grow by 43.82% on average per year.
SPNT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.19% yearly.
EPS Next Y128.72%
EPS Next 2Y59.47%
EPS Next 3Y43.82%
EPS Next 5YN/A
Revenue Next Year-3.68%
Revenue Next 2Y1.26%
Revenue Next 3Y3.19%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SPNT Yearly Revenue VS EstimatesSPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
SPNT Yearly EPS VS EstimatesSPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.21, the valuation of SPNT can be described as rather expensive.
Based on the Price/Earnings ratio, SPNT is valued a bit more expensive than 72.11% of the companies in the same industry.
SPNT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.77.
SPNT is valuated cheaply with a Price/Forward Earnings ratio of 7.37.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SPNT indicates a somewhat cheap valuation: SPNT is cheaper than 74.15% of the companies listed in the same industry.
SPNT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.23.
Industry RankSector Rank
PE 20.21
Fwd PE 7.37
SPNT Price Earnings VS Forward Price EarningsSPNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SPNT is valued a bit cheaper than 79.59% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SPNT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 15.11
EV/EBITDA 5.05
SPNT Per share dataSPNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SPNT's earnings are expected to grow with 43.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y59.47%
EPS Next 3Y43.82%

0

5. Dividend

5.1 Amount

SPNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SIRIUSPOINT LTD

NYSE:SPNT (10/21/2025, 8:04:01 PM)

After market: 17.99 0 (0%)

17.99

+0.23 (+1.3%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-04 2025-08-04/bmo
Earnings (Next)10-29 2025-10-29
Inst Owners87.27%
Inst Owner Change0.45%
Ins Owners2.12%
Ins Owner Change1.87%
Market Cap2.10B
Revenue(TTM)2.79B
Net Income(TTM)103.20M
Analysts82.22
Price Target25.5 (41.75%)
Short Float %1.67%
Short Ratio1.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP15.5%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)47.55%
Min EPS beat(2)-13.77%
Max EPS beat(2)108.87%
EPS beat(4)1
Avg EPS beat(4)-19.49%
Min EPS beat(4)-131.86%
Max EPS beat(4)108.87%
EPS beat(8)5
Avg EPS beat(8)16.37%
EPS beat(12)7
Avg EPS beat(12)26.15%
EPS beat(16)9
Avg EPS beat(16)12.25%
Revenue beat(2)0
Avg Revenue beat(2)-10.27%
Min Revenue beat(2)-11.21%
Max Revenue beat(2)-9.34%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.7%
EPS NQ rev (1m)-36.93%
EPS NQ rev (3m)-36.34%
EPS NY rev (1m)1.81%
EPS NY rev (3m)0.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.36%
Valuation
Industry RankSector Rank
PE 20.21
Fwd PE 7.37
P/S 0.75
P/FCF 15.11
P/OCF 15.11
P/B 1
P/tB 1.07
EV/EBITDA 5.05
EPS(TTM)0.89
EY4.95%
EPS(NY)2.44
Fwd EY13.57%
FCF(TTM)1.19
FCFY6.62%
OCF(TTM)1.19
OCFY6.62%
SpS23.85
BVpS18.03
TBVpS16.88
PEG (NY)0.16
PEG (5Y)N/A
Graham Number19
Profitability
Industry RankSector Rank
ROA 0.84%
ROE 4.9%
ROCE 3.19%
ROIC 2.77%
ROICexc 2.95%
ROICexgc 4.08%
OM 14.14%
PM (TTM) 3.71%
GM N/A
FCFM 4.99%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-10.36%
ROICexc growth 3YN/A
ROICexc growth 5Y-11.48%
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.88
Debt/EBITDA 1.67
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 34.29%
Profit Quality 134.69%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.5%
ROIC/WACC0.33
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.66%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%-12.28%
EPS Next Y128.72%
EPS Next 2Y59.47%
EPS Next 3Y43.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.01%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%-12.28%
Revenue Next Year-3.68%
Revenue Next 2Y1.26%
Revenue Next 3Y3.19%
Revenue Next 5YN/A
EBIT growth 1Y-10.62%
EBIT growth 3YN/A
EBIT growth 5Y17.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-69.41%
FCF growth 3Y260.08%
FCF growth 5Y-11.94%
OCF growth 1Y-69.41%
OCF growth 3Y260.08%
OCF growth 5Y-11.94%